Plasma brain natriuretic peptide at rest and after adenosine-induced myocardial ischemia in normotensive and essential hypertensive patients with suspected coronary artery disease

Peptides

Volumn 30, Issue 2, 2009, Pages 385-390

  Fontana, Fiorella ^a   Bernardi, Pasquale ^a   Pizzi, Carmine ^a   Di Toro, Rosanna ^b   Spampinato, Santi ^b   Merlo Pich, Emilio ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Dipartimento di Matematica   (Italy)

^c GSK   (Italy)

Author keywords

Adenosine; Brain natriuretic peptide; Coronary artery disease; Essential hypertension; Myocardial ischemia; Myocardial scintigraphy

Indexed keywords

ADENOSINE; BRAIN NATRIURETIC PEPTIDE; TETROFOSMIN TC 99M;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ESSENTIAL HYPERTENSION; EXERCISE TEST; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADENOSINE; AGED; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 58149498542     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.09.018     Document Type: Article

References (37)

1. Berman D.S., Kiat H., Friedman J.D., Wang F.P., van Train K., Matzer L., et al. Separate acquisition rest thallium-201/stress tecnetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol 22 (1993) 1455-1464
2. Cerqueira M.D., Weissman N.J., Dilsizian V., Jacobs A.K., Kaul S., Laskey W.K., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 (2002) 539-542
3. Cheung B.M., and Brown M.J. Plasma brain natriuretic peptide and C-type natriuretic peptide in essential hypertension. J Hypertens 12 (1994) 449-454
4. Darbar D., Davidson N.C., Gillespie N., Choy A.M., Lang C.C., Shyr Y., et al. Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction. Am J Cardiol 78 (1996) 284-287
5. De Lemos J.A., Morrow D.A., Bentley J.H., Omland T., Sabatine M.S., McCabe C.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
6. Fontana F., Bernardi P., Merlo Pich E., Boschi S., De Iasio R., Spampinato S., et al. Opioid peptide modulation of circulatory and endocrine response to mental stress in humans. Peptides 18 (1997) 169-175
7. Goetze J.P., Christoffersen C., Perko M., Arendrup H., Rehfeld J.F., Kastrup J., et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 17 (2003) 1105-1107
8. Grewal J., McKelvie R., Lonn E., Tait P., Carlsson J., Gianni M., et al. BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction. Eur J Fail 10 (2008) 252-259
9. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 17 (1999) 151-183
10. Hopkins W.E., Chen Z., Fukagawa N.K., Hall C., Knot H.J., and Le Winter M.M. Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation 109 (2004) 2872-2877
11. Kohono M., Horio H., Yokokawa K., Murakawa K., Yasunari K., Akioka K., et al. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 92 (1992) 29-34
12. Kohono M., Yasunari K., Yokokawa K., Horio T., Kano H., Minami M., et al. Plasma brain natriuretic peptide during ergometric exercise in hypertensive patients with left ventricular hypertrophy. Metabolism 45 (1996) 1326-1329
13. Kurz K., Voelker R., Zdunek D., Wergeland R., Hess G., Ivandic B., et al. Effect of stress-induced reversible ischemia on serum concentrations of ischemia-modified albumin, natriuretic peptides and placental growth factor. Clin Res Cardiol 96 (2007) 152-159
14. Lainscak M., von Haehling S., Springer J., and Anker S.D. Biomarkers for chronic heart failure. Heart Fail Monit 5 (2007) 77-82
15. Levin E.R., Gardner D.G., and Samson W. Natriuretic peptides. N Engl J Med 339 (1998) 321-328
16. Lim H.S., Patel J.V., Nadar S., Hughes E.A., and Lip G.Y. Comparison of brain natriuretic peptide and left ventricular diastolic function determined by tissue Doppler in patients with diabetes mellitus, patients with hypertension without diabetes, and in healthy subjects. Am J Cardiol 95 (2005) 905-908
17. Maeda K., Tsutamoto T., Wada A., Hisanaga T., and Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 135 (1998) 825-832
18. Manfrini O., Pizzi C., Morgagni G.L., Fontana F., and Bugiardini R. Effect of pravastatin on myocardial perfusion after percutaneous transluminal coronary angioplasty. Am J Cardiol 93 (2004) 1391-1393
19. McDonagh T.A., Robb S.D., Murdoch D.R., Morton J.J., Ford I., Morrison C.E., et al. Biochemical detection of left ventricular systolic dysfunction. Lancet 351 (1998) 9-13
20. Mukoyama M., Nakao K., Saito Y., Ogawa Y., Hosoda K., Suga S., et al. Increased human brain natriuretc peptide in congestive heart failure. N Engl J Med 323 (1990) 757-758
21. Murakami Y., Shimada T., Inoue S., Shimizu H., Ohta Y., Katoh H., et al. New insights into the mechanism of the elevation of plasma brain natriuretic polypeptide levels in patients with left ventricular hypertrophy. Can J Cardiol 18 (2002) 1294-1300
22. Nielsen O.W., Cowburn P.J., Sajadieh A., Morton J.J., Dargie H., and McDonagh T. Value of BNP to estimate cardiac risk in patients on cardioactive treatment in primary care. Eur J Heart Fail 9 (2007) 1178-1185
23. Nishikimi T., Morimoto A., Ishikawa K., Saito Y., Kangawa K., Matsuo H., et al. Different secretion patterns of adrenomedullin, brain natriuretic peptide, and atrial natriuretic peptide during exercise in hypertensive and normotensive subjects. Clin Exp Hypertens 19 (1997) 503-518
24. Palumbo B., Siepi D., Lupattelli G., Sinzinger H., Fiorucci G., Anniboletti P.F., et al. Usefulness of brain natriuretic peptide levels to discriminate patients with stable angina pectoris without and with electrocardiographic myocardial ischemia and patients with healed myocardial infarction. Am J Cardiol 94 (2004) 780-783
25. Redfield M.M., Rodeheffer R.J., Jacobsen S.J., Mahoney D.W., Bailey K.R., and Burnett Jr. J.C. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 40 (2002) 976-982
26. Sabatine M.S., Morrow D.A., de Lemos J.A., Omland T., Desai M.Y., Tanasijevic M., et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 44 (2004) 1988-1995
27. Salinas G., Daher I.N., Okorodudu A.O., and Ahmad M. B-type natriuretic peptide is not a marker of ischemia during dobutamine stress echocardiography. J Am Soc Echocardiogr 20 (2007) 23-26
28. Staub D., Nusbaumer C., Zellweger M.J., Jonas N., Wild D., Pfisterer M.E., et al. Use of B-type natriuretic peptide in the detection of myocardial ischemia. Am Heart J 151 (2006) 1223-1230
29. Struthers A.D., and Davies J. B-type natriuretic peptide: a simple new test to identify coronary heart disease. QJM 98 (2005) 765-769
30. Tanaka M., Ishizaka Y., Ishiyama Y., Kato J., Kida O., Kitamura K., et al. Chronic effect of beta-adrenoceptor blockade on plasma levels of brain natriuretic peptide during exercise in essential hypertension. Hypertens Res 19 (1996) 239-245
31. Toth M., Vuorinen K.H., Vuolteenaho O., Hassinen I.E., Uusimaa P.A., Leppaluoto J., et al. Hypoxia stimulates release of ANP and BNP from perfused rat ventricular myocardium. Am J Physiol 266 (1994) H1572-H1580
32. Vanderheyden M., Goethals M., Verstreken S., De Bruyne B., Muller K., Van Schuerbeeck E., et al. Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy. J Am Coll Cardiol 44 (2004) 2349-2354
33. Win H.K., Chang S.M., Raizner M., Shah G., Al Basky F., Desai U., et al. Percent change in B-type natriuretic peptide levels during treadmill exercise as a screening test for exercise-induced myocardial ischemia. Am Heart J 150 (2005) 695-700
34. Wolber T., Maeder M., Rickli H., Riesen W., Binggeli C., Duru F., et al. N-terminal pro-brain natriuretic peptide used for the prediction of coronary artery stenosis. Eur J Clin Invest 37 (2007) 18-25
35. Wong K.Y., McSwiggan S., Kennedy N.S., Macwalter R.S., and Struthers A.D. BNP identifies silent myocardial ischaemia in stroke survivors. Heart 92 (2006) 487-489
36. Yasumoto K., Takata M., Ueno H., Tomita S., Tomoda F., and Inoue H. Relation of plasma brain and atrial natriuretic peptides to left ventricular geometric patterns in essential hypertension. Am J Hypertens 12 (1999) 921-924
37. Zaid G., Tanchilevitch A., Rivlin E., Gropper R., Rosenschein U., Lanir A., et al. Diagnostic accuracy of serum B-type natriuretic peptide for myocardial ischemia detection during exercise testing with spect perfusion imaging. Int J Cardiol 117 (2007) 157-164